Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.55
-0.23 (-3.39%)
At close: Sep 11, 2026, 4:00 PM EDT
6.77
+0.22 (3.36%)
After-hours: Sep 11, 2026, 5:02 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $441.08 million as of September 11, 2026. Its market cap has decreased by -22.66% in one year.
Market Cap
441.08M
Enterprise Value
543.03M
1-Year Change
-22.66%
Ranking
Category
Stock Price
$6.55
ChartMarket Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $441.08M, a decrease of -79.79%. That is a compound annual growth rate of -25.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 441.08M | -6.61% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 489.75M |
| Puma Biotechnology | 484.71M |
| Evommune | 474.70M |
| Editas Medicine | 465.35M |
| Rezolute | 459.65M |
| Atea Pharmaceuticals | 455.56M |
| Relmada Therapeutics | 453.35M |
| Ocugen | 451.02M |